يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"M. Harit"', وقت الاستعلام: 0.43s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Epidemiology and Vaccinal Prevention; Том 21, № 5 (2022); 21-28 ; Эпидемиология и Вакцинопрофилактика; Том 21, № 5 (2022); 21-28 ; 2619-0494 ; 2073-3046

    وصف الملف: application/pdf

    Relation: https://www.epidemvac.ru/jour/article/view/1671/872; Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 397 (10275) p. 671–681. doi:10.1016/S0140-6736(21)00234-8.; Tukhvatulin AI, Dolzhikova IV, Shcheblyakov DV, et al. An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine Sputnik Light for prevention of coronavirus infection in healthy adults. Lancet Reg Health Eur. 2021, 11:100241.; CDC COVID-19 Vaccine Breakthrough Case Investigations Team. COVID-19 vaccine breakthrough infections reported to CDC – United States, january 1 april 30, 2021. MMWR Morb Mortal Wkly Rep.2021, 28 may; 70 (21): р. 792–793.; Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021, р. 939–949. doi:10.1016/S1473-3099(21)00224-3.; Dagan N, Barda N, Kepten E, et al. Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021, Apr 15; 384(15):1412–1423. doi:10.1056/NEJMoa2101765.; Tenforde MW, Embi PJ, Levy ME, et al. Influenza and Other Viruses in the Acutely Ill (IVY) Network. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. JAMA. 2021;326:2043–54. doi:10.1001/jama.2021.19499.; Jabłońska K, Aballéa S, Toumi M. The real-life impact of vaccination on COVID-19 mortality in Europe and Israel. Public Health. 2021. Sep;198:230–237. DOI:10.1016/j.puhe.2021.07.037; Xu S, Heing-Becker I, Zhang J, et al. COVID-19 Vaccination and Non-COVID-19 Mortality Risk Seven Integrated Health Care Organizations, United States, December 14, 2020July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1520–1524.; Vaishya R, Gupta BM, Kappi M, et al. Symptomatic post-vaccination SARS-CoV-2 infections in healthcare workers – A multicenter cohort study. Diabetes Metab Syndr. 2021 Oct 4; 15 (6):102306.; Rovida F, Esposito GL, Rissone M, et al. SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers. Nat Commun. 2021 Oct 15; 12 (1): 6032.; Liu C, Sun H, Yi Y, Shen W, et al. Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness // medRxiv [Preprint]. 2021 Oct 7:2021.10.05.21264583.; Brown CM, Vostok J, Johnson H, et al. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 6;70(31):1059–1062.; Naito T, Yan Yan,Yoko Tabe, et al. Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan. Hum Vaccin Immunother. 2021 Oct 6:1–2.; Hacisuleyman E, Hale C, Saito Y, et al. Vaccine Breakthrough Infections with SARS-CoV-2 Variants. N Engl J Med. 2021 Jun 10; 384(23):2212–2218.; Jain VK, Yengar KP, Ish P. Elucidating causes of COVID-19 infection and related deaths after vaccination. Diabetes Metab Syndr. 2021 Sep-Oct; 15 (5): 102212. doi:10.1016/j.dsx.2021.102212. Epub 2021 Jul 15. 1; Wang R, Chen J, Hozumi Yu, et al. Emerging vaccine-breakthrough SARS-CoV-2 variants. ArXiv. 2021 Sep 9: arXiv:2109.04509v1.; Wang L, WangQQ, Pamela BD, et al. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry. 2021 Oct 5.; https://www.epidemvac.ru/jour/article/view/1671

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal